SO-26 Clinical efficacy of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients
Ryan B. Corcoran, Marios Giannakis, Jill N. Allen, J. Chen, Karin Pelka, Serena H. Chao, Jeffrey A. Meyerhardt, Andrea C. Enzinger, Peter C. Enzinger, Nadine J. McCleary, M. Yugelun, Thomas A. Abrams, Katie Kanter, Emily Van Seventer, William B. Bradford, Isobel J. Fetter, Giulia Siravegna, Jinwei Tian, Jeffrey W. Clark, David P. Ryan, Nir Hacohen, Aparna R. Parikh
Topics & Concepts
MedicineColorectal cancerOncologyInternal medicineCancer researchMEK inhibitorCancerKinaseMAPK/ERK pathwayGeneticsBiologyColorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsColorectal and Anal Carcinomas